CPT code 33215 covers the repositioning of an electrode already implanted in the right atrium or right ventricle for a pacemaker or implantable cardioverter-defibrillator that is malfunctioning due to lead dislodgement or improper placement. This procedure is clinically important because lead issues can cause ineffective pacing or inappropriate shocks, requiring timely reintervention to restore device function and patient safety. Nationally, interventions to correct lead position influence utilization patterns in electrophysiology and have implications for hospital resource use and device-related quality metrics.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for CPT code 33215, common billing modifiers associated with device procedures, typical sites of service, and payer coverage considerations. The publication provides benchmarks for utilization and reimbursement patterns, highlights relevant policy updates affecting device revision procedures, and presents clinical considerations tied to service setting and procedure indications. Data not available in the input for specific associated taxonomies, ICD-10 diagnoses, related codes, and service line are noted as unavailable where applicable.